{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:38:58Z","timestamp":1793723938685,"version":"4.6.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2016.01.019","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T01:07:10Z","timestamp":1453252030000},"page":"1025-1033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles"],"prefix":"10.1016","volume":"34","author":[{"given":"Merijn L.M.","family":"Salverda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne M.","family":"Meinderts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik-Jan","family":"Hamstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Wagemakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joppe W.R.","family":"Hovius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"van der Ark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Stork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van der Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.01.019_bib0315","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/MMBR.00031-09","article-title":"Virulence and immunomodulatory roles of bacterial outer membrane vesicles","volume":"74","author":"Ellis","year":"2010","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0320","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.0805532107","article-title":"Delivery of foreign antigens by engineered outer membrane vesicle vaccines","volume":"107","author":"Chen","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0325","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1128\/IAI.00950-10","article-title":"Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae","volume":"79","author":"Muralinath","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0330","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.4049\/jimmunol.179.11.7692","article-title":"Membrane vesicles are immunogenic facsimiles of Salmonella typhimurium that potently activate dendritic cells, prime B and T cell responses, and stimulate protective immunity in vivo","volume":"179","author":"Alaniz","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0335","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.vaccine.2013.12.048","article-title":"Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes","volume":"32","author":"Gaillard","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0340","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1016\/j.vaccine.2010.05.006","article-title":"Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine","volume":"28","author":"Zollinger","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0345","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CVI.00119-14","article-title":"A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis","volume":"21","author":"Nieves","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0350","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1016\/j.vaccine.2011.08.121","article-title":"Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice","volume":"29","author":"Camacho","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0355","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.4049\/jimmunol.1200742","article-title":"Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses","volume":"190","author":"Kim","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0360","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0928-8244(03)00091-9","article-title":"Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens","volume":"36","author":"Keenan","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0365","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1016\/j.vaccine.2008.07.004","article-title":"Outer membrane vesicles as acellular vaccine against pertussis","volume":"26","author":"Roberts","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0370","doi-asserted-by":"crossref","first-page":"20181","DOI":"10.3402\/jev.v2i0.20181","article-title":"Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro","volume":"2","author":"Bartolini","year":"2013","journal-title":"J Extracellular Vesicles"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.01.019_bib0375","doi-asserted-by":"crossref","first-page":"B3","DOI":"10.1016\/j.vaccine.2009.04.071","article-title":"Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis","volume":"27","author":"Holst","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0380","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1016\/j.vaccine.2007.01.022","article-title":"Safety review: two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease","volume":"25","author":"Nokleby","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0385","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4161\/hv.18500","article-title":"Bexsero: a multicomponent vaccine for prevention of meningococcal disease","volume":"8","author":"Gorringe","year":"2012","journal-title":"Hum Vaccine Immunother"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0390","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fimmu.2014.00121","article-title":"Bacterial outer membrane vesicles and vaccine applications","volume":"5","author":"Acevedo","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0395","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1074\/jbc.M307628200","article-title":"Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles","volume":"279","author":"Kesty","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0400","doi-asserted-by":"crossref","first-page":"24015","DOI":"10.3402\/jev.v3.24015","article-title":"Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen","volume":"3","author":"Fantappie","year":"2014","journal-title":"J Extracellular Vesicles"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0405","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/IAI.01139-08","article-title":"Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera","volume":"77","author":"Schild","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0410","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jmb.2008.03.076","article-title":"Engineered bacterial outer membrane vesicles with enhanced functionality","volume":"380","author":"Kim","year":"2008","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0415","doi-asserted-by":"crossref","first-page":"e1002966","DOI":"10.1371\/journal.ppat.1002966","article-title":"Immunity to intracellular Salmonella depends on surface-associated antigens","volume":"8","author":"Barat","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0420","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1128\/AEM.01941-14","article-title":"Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach","volume":"80","author":"Daleke-Schermerhorn","year":"2014","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0425","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1016\/j.vaccine.2013.12.026","article-title":"The delicate balance in genetically engineering live vaccines","volume":"32","author":"Galen","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0430","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1073\/pnas.93.4.1458","article-title":"Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis","volume":"93","author":"Hess","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0435","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0928-8244(03)00063-4","article-title":"Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization","volume":"37","author":"Kang","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0440","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12934-014-0162-8","article-title":"An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines","volume":"13","author":"Jong","year":"2014","journal-title":"Microb Cell Factories"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0445","doi-asserted-by":"crossref","first-page":"e97103","DOI":"10.1371\/journal.pone.0097103","article-title":"Positional assembly of enzymes on bacterial outer membrane vesicles for cascade reactions","volume":"9","author":"Park","year":"2014","journal-title":"PloS one"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0450","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0958-1669(00)00131-2","article-title":"Expressing genes in different Escherichia coli compartments","volume":"11","author":"Cornelis","year":"2000","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0455","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1016\/j.vaccine.2009.08.106","article-title":"Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses","volume":"27","author":"Schroeder","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0460","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.copbio.2010.07.009","article-title":"Extracellular production of recombinant proteins using bacterial autotransporters","volume":"21","author":"Jong","year":"2010","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0465","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/MMBR.00011-07","article-title":"The autodisplay story, from discovery to biotechnical and biomedical applications","volume":"71","author":"Jose","year":"2007","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0470","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nbt0698-576","article-title":"Surface display of Zymomonas mobilis levansucrase by using the ice-nucleation protein of Pseudomonas syringae","volume":"16","author":"Jung","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0475","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1126\/science.285.5428.732","article-title":"Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors","volume":"285","author":"Brightbill","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0480","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.291.5508.1544","article-title":"Induction of direct antimicrobial activity through mammalian toll-like receptors","volume":"291","author":"Thoma-Uszynski","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0485","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJM199807233390402","article-title":"A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium","volume":"339","author":"Sigal","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0490","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0495","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1128\/CVI.00406-14","article-title":"A novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi Sensu Lato","volume":"21","author":"Wressnigg","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0500","doi-asserted-by":"crossref","first-page":"e113294","DOI":"10.1371\/journal.pone.0113294","article-title":"Design and development of a novel vaccine for protection against Lyme borreliosis","volume":"9","author":"Comstedt","year":"2014","journal-title":"PloS one"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0505","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1126\/science.2237407","article-title":"Protection of mice against the Lyme disease agent by immunizing with recombinant OspA","volume":"250","author":"Fikrig","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0510","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0515","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0520","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1086\/589308","article-title":"Bactericidal antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed factor H-binding protein and genetically attenuated endotoxin","volume":"198","author":"Koeberling","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0525","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1016\/j.vaccine.2010.04.082","article-title":"Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process","volume":"28","author":"van de Waterbeemd","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0530","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-micro-090110-102859","article-title":"Lipoprotein sorting in bacteria","volume":"65","author":"Okuda","year":"2011","journal-title":"Ann Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0535","series-title":"Vaccines","first-page":"1122","article-title":"Lyme disease vaccines","author":"Steere","year":"2013"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0540","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1128\/IAI.69.10.5981-5990.2001","article-title":"Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity","volume":"69","author":"van der Ley","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0545","doi-asserted-by":"crossref","first-page":"9417","DOI":"10.1073\/pnas.0402340101","article-title":"Identification of an outer membrane protein required for the transport of lipopolysaccharide to the bacterial cell surface","volume":"101","author":"Bos","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0550","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1128\/JCM.38.7.2611-2621.2000","article-title":"Antibodies against specific proteins of and immobilizing activity against three strains of Borrelia burgdorferi sensu lato can be found in symptomatic but not in infected asymptomatic dogs","volume":"38","author":"Hovius","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0555","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0378-1119(89)90359-4","article-title":"Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension","volume":"77","author":"Horton","year":"1989","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0560","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1084\/jem.20031960","article-title":"Essential role for OspA\/B in the life cycle of the Lyme disease spirochete","volume":"199","author":"Yang","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0565","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1074\/jbc.M808831200","article-title":"Structural basis for the immunogenic properties of the meningococcal vaccine candidate LP2086","volume":"284","author":"Mascioni","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0570","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1073\/pnas.94.8.3584","article-title":"Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab","volume":"94","author":"Li","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0575","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/JB.01308-09","article-title":"Expression of factor H binding protein of meningococcus responds to oxygen limitation through a dedicated FNR-regulated promoter","volume":"192","author":"Oriente","year":"2010","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0580","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1128\/JB.06042-11","article-title":"Probing the Borrelia burgdorferi surface lipoprotein secretion pathway using a conditionally folding protein domain","volume":"193","author":"Chen","year":"2011","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0585","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/76494","article-title":"Surface-displayed viral antigens on Salmonella carrier vaccine","volume":"18","author":"Lee","year":"2000","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0590","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1128\/IAI.71.11.6320-6328.2003","article-title":"Autodisplay: efficacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strains","volume":"71","author":"Rizos","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0595","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/IAI.00682-10","article-title":"Lipoproteins of bacterial pathogens","volume":"79","author":"Kovacs-Simon","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0600","series-title":"Surface localization determinants of Borrelia burgdorferi lipoproteins","author":"Kumru","year":"2011"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0605","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1365-2958.2010.07172.x","article-title":"Translocation of Borrelia burgdorferi surface lipoprotein OspA through the outer membrane requires an unfolded conformation and can initiate at the C-terminus","volume":"76","author":"Schulze","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0610","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1111\/j.1365-2958.2006.05039.x","article-title":"Borrelia burgdorferi lipoproteins are secreted to the outer surface by default","volume":"59","author":"Schulze","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0615","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1073\/pnas.1111413109","article-title":"Identification of a common immune signature in murine and human systemic Salmonellosis","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.01.019_bib0620","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/IAI.70.1.240-248.2002","article-title":"Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major","volume":"70","author":"Cote-Sierra","year":"2002","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T04:41:28Z","timestamp":1600058488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16000542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X16000542"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}